Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ammassari

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Annals of Internal Medicine|April 3, 2001
Adherence to protease inhibitorsR Murri, A Ammassari, A Antinori
AIDS (London, England)|August 1, 1996
Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxisA Antinori, R Murri, A Ammassari
Lancet (London, England)|June 17, 1999
Definition and measurement of adherence to antiretroviral drugs in HIV-1-infected patientsR Murri, A Ammassari, A De Luca, et al.
Current Topics in Microbiology and Immunology|January 1, 1996
AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatmentA Ammassari, R Murri, A Cingolani, et al.
Lancet (London, England)|August 5, 1998
"Buffalo hump" in HIV-1 infectionA De Luca, R Murri, F Damiano, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1995
Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case-control studyA Ammassari, A Linzalone, R Murri, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Evaluation of different staging systems for Kaposi's sarcoma in HIV-infected patientsA Antinori, I Izzi, A Ammassari, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|November 1, 1996
Karnofsky performance status and assessment of global health statusR Murri, G Scoppettuolo, F Damiano, et al.
AIDS (London, England)|October 29, 1998
Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapyA De Luca, A Ammassari, A Cingolani, et al.
JAMA|March 3, 1999
Use of antiretroviral therapy by intravenous drug users with HIVR Murri, A Ammassari, A De Luca, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Annals of Internal Medicine|April 3, 2001
Adherence to protease inhibitorsR Murri, A Ammassari, A Antinori
AIDS (London, England)|August 1, 1996
Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxisA Antinori, R Murri, A Ammassari
Lancet (London, England)|June 17, 1999
Definition and measurement of adherence to antiretroviral drugs in HIV-1-infected patientsR Murri, A Ammassari, A De Luca, et al.
Current Topics in Microbiology and Immunology|January 1, 1996
AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatmentA Ammassari, R Murri, A Cingolani, et al.
Lancet (London, England)|August 5, 1998
"Buffalo hump" in HIV-1 infectionA De Luca, R Murri, F Damiano, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1995
Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case-control studyA Ammassari, A Linzalone, R Murri, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Evaluation of different staging systems for Kaposi's sarcoma in HIV-infected patientsA Antinori, I Izzi, A Ammassari, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|November 1, 1996
Karnofsky performance status and assessment of global health statusR Murri, G Scoppettuolo, F Damiano, et al.
AIDS (London, England)|October 29, 1998
Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapyA De Luca, A Ammassari, A Cingolani, et al.
JAMA|March 3, 1999
Use of antiretroviral therapy by intravenous drug users with HIVR Murri, A Ammassari, A De Luca, et al.
Pageof 7